A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c02093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Antonio Laghezza und 17 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", via Orabona 4, 70125 Bari, Italy. Hauptthemen laut MEDLINE: PPAR alpha, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Universita degli Studi di Bari Aldo Moro, Ministero dell'Universit? e della Ricerca, Universit? degli Studi di Firenze.
Abstract (Originalsprache)
A new series of analogues or derivatives of the previously reported PPARα/γ dual agonist LT175 allowed the identification of ligand 10, which was able to potently activate both PPARα and -γ subtypes as full and partial agonists, respectively. Docking studies were performed to provide a molecular explanation for this different behavior on the two different targets. In vivo experiments showed that this compound induced a significant reduction in blood glucose and lipid levels in an STZ-induced diabetic mouse model displaying no toxic effects on bone, kidney, and liver. By examining in depth the antihyperglycemic activity of 10, we found out that it produced a slight but significant inhibition of the mitochondrial pyruvate carrier, acting also through insulin-independent mechanisms. This is the first example of a PPARα/γ dual agonist reported to show this inhibitory effect representing, therefore, the potential lead of a new class of drugs for treatment of dyslipidemic type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dipartimento Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", via Orabona 4, 70125 Bari, Italy.
- Dipartimento di Farmacia, "Drug Discovery" Laboratory, Università degli Studi di Napoli "Federico II", via D. Montesano 49, 80131 Napoli, Italy.
- Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Sezione di Scienze Biochimiche, Università degli Studi di Firenze, Viale Morgagni 50, 50134 Firenze, Italy.
- Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand 835215, India.
- Adgyl Lifesciences Private Ltd., Bengaluru 560058, India.
- Bioanalytical Section, Eurofins Advinus Biopharma Services India Pvt. Ltd., Bengaluru 560058, India.
ORCID-Profile: Antonio Laghezza, Carmen Cerchia, Rosalba Leuci, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Sudeep Ca, Paolo Paoli, Antonio Lavecchia, Fulvio Loiodice
Förderung
- Universita degli Studi di Bari Aldo Moro
- Ministero dell'Universit? e della Ricerca
- Universit? degli Studi di Firenze
Zitieren
APA
Laghezza, A., Cerchia, C., Genovese, M., Leuci, R., Pranzini, E., Santi, A., Brunetti, L., Piemontese, L., Tortorella, P., Biswas, A., Singh, R. P., Tambe, S., Ca, S., Pattnaik, A. K., Jayaprakash, V., Paoli, P., Lavecchia, A., & Loiodice, F. (2023). A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c02093
Vancouver
Laghezza A, Cerchia C, Genovese M, Leuci R, Pranzini E, Santi A, et al. A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c02093
BibTeX
@article{Laghezza2023,
author = {Laghezza, Antonio and Cerchia, Carmen and Genovese, Massimo and Leuci, Rosalba and Pranzini, Erica and Santi, Alice and Brunetti, Leonardo and Piemontese, Luca and Tortorella, Paolo and Biswas, Abanish and Singh, Ravi Pratap and Tambe, Suhas and Ca, Sudeep and Pattnaik, Ashok Kumar and Jayaprakash, Venkatesan and Paoli, Paolo and Lavecchia, Antonio and Loiodice, Fulvio},
title = {A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c02093}
}
EUVIMED